Patient presents with concerns consistent with hypogonadism.  Symptoms include [Specify symptoms e.g., decreased libido, erectile dysfunction, fatigue, muscle weakness, loss of body hair, decreased bone density, infertility, gynecomastia in males, hot flashes in males, irregular menses in females].  Onset of symptoms was [Specify timeframe e.g., gradual over several months, sudden onset following [event], etc.].  Patient reports [Specify relevant patient-reported history e.g., prior testicular injury, history of mumps orchitis, family history of Kallmann syndrome, exposure to toxins, chronic illness, use of medications such as opioids or glucocorticoids, chemotherapy or radiation exposure].  Physical examination reveals [Specify relevant findings e.g., small testicular volume in males, decreased muscle mass, increased body fat, sparse body hair].  Differential diagnosis includes primary hypogonadism, secondary hypogonadism, Klinefelter syndrome, Kallmann syndrome,  pituitary adenoma,  and medication-induced hypogonadism.  Initial laboratory testing ordered includes [Specify tests e.g., serum testosterone levels  free and total, LH, FSH, estradiol, prolactin, iron studies, CBC, CMP, lipid panel, bone density scan].  Treatment plan includes [Specify treatment plan e.g.,  testosterone replacement therapy TRT,  referral to endocrinology,  lifestyle modifications including diet and exercise,  genetic counseling if indicated,  addressing underlying medical conditions].  Patient education provided regarding the diagnosis, treatment options, potential benefits and risks of treatment, and the importance of follow-up care. Follow-up appointment scheduled in [Specify timeframe e.g., 4 weeks] to review laboratory results and assess treatment response. The patient verbalized understanding of the plan.  ICD-10 code [Specify appropriate code e.g., E29.1,  N95.1, Q98.2] is considered pending further diagnostic evaluation.